Filing Flows › Beam Therapeutics (BEAM) › Q2 2026 › vs Q1 2026
Beam Therapeutics (BEAM) Q2 2026 vs Q1 2026 (quarter over quarter)
Beam Therapeutics's revenue fell $31.2M (-98%) from $31.7M in Q1 2026 to $490K in Q2 2026.
Beam Therapeutics, Q2 2026: revenue $490K (-94% year over year), net loss $123M, operating cash flow −$66.1M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $490K | $31.7M | −$31.2M | -98% |
| Other income, net | $3.9M | $12.9M | −$9.0M | -70% |
| Net loss | $123M | $94.3M | $28.4M | +30% |
| Costs & expenses | $127M | $139M | −$11.9M | -9% |
| Operating costs | $127M | $139M | −$11.9M | -9% |
| Research & development | $95.1M | $105M | −$9.4M | -9% |
| General & admin | $31.9M | $34.4M | −$2.5M | -7% |
| Operating cash sources | $123M | $94.3M | $28.4M | +30% |
| Depreciation | $5.4M | $5.6M | −$195K | -3% |
| Share-based compensation | $19.3M | $19.0M | $234K | +1% |
| Working capital & other | $31.9M | −$58.8M | $90.7M | — |
| Cash used in operations | $66.1M | $129M | −$62.4M | -49% |
| Net loss absorbed | $123M | $94.3M | $28.4M | +30% |
Questions
How much did Beam Therapeutics's revenue grow quarter over quarter in Q2 2026?
Beam Therapeutics's revenue fell $31.2M (-98%) from $31.7M in Q1 2026 to $490K in Q2 2026.